chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 63.0
Sex: F
Vaccine: VARZOS, VARZOS, VARZOS
Symptoms: Pruritus, Rash
Clinical narrative: Information has been received from a nurse practitioner concerning a 63 year old female who on 19-JAN-2007 was vaccinated with a dose of Zostavax (lot # 654603/1405F). There was no concomitant medication. On 21-JAN-2007 the patient developed arm soreness and cold like symptoms. Medical attention was sought. The patient was treated with lidocaine cream for her sore arm. There was no product quality complaint involved. No further information was available. Additional information has been requested. This is in follow-up to report(s) previously submitted on 3/14/2007: 6/22/2007. Information has been received from a 63 year old female consumer with a compromised immune system, fibromyalgia, asthma, allergies to codeine, vicodin, iron, keflex, pamelor, all anti-inflammatory medicines, all anti-depressant medicines, all anti-seizure medicines and levaquin and chilli pepper allergy who on 19-JAN-2007 was vaccinated with a 0.65 ml dose of ZOSTAVAX (Merck) (lot # 652966/0722P). Concomitant therapy included SYNTHROID, LIPITOR, Ateolol (manufacturer unknown) and omeprazole (MSD). "Two days later," on 21-JAN-2007 the patient developed swollen lymph nodes in her neck, knots "all up and down" her arm (also reported as 3 knots on her arm above the injection site), a large red rash on the injection arm, pain all over her body, a sore stiff neck, a burning sensation inside her nose, and her chest teele itchy in the respiratory area. The patient reported that she also experienced a cough that she developed 48-72 hours after vaccination. It was reported that the side effects have gotten increasingly worse. Unspecified medical attention was sought. At the time of the report the patient had not recovered. Follow-up information from the patient's primary physician stated that his office did not administer the vaccine and did not have any additional information. Additional information was received from the consumer who reported that the lot number previously provided was incorrect. The correct ZOSTAVAX (Merck) lot number is 654003/1405F. The consumer also reported that she has not had any improvement. The pain in her neck and shoulders was worse and it triggered and episode of fibromyalgia. Additional information has been requested.
Age: 63.0
Sex: F
Vaccine: VARZOS, VARZOS, VARZOS
Symptoms: Burning sensation, Cough, Injection site mass, Lymphadenopathy, Musculoskeletal stiffness
Clinical narrative: Information has been received from a nurse practitioner concerning a 63 year old female who on 19-JAN-2007 was vaccinated with a dose of Zostavax (lot # 654603/1405F). There was no concomitant medication. On 21-JAN-2007 the patient developed arm soreness and cold like symptoms. Medical attention was sought. The patient was treated with lidocaine cream for her sore arm. There was no product quality complaint involved. No further information was available. Additional information has been requested. This is in follow-up to report(s) previously submitted on 3/14/2007: 6/22/2007. Information has been received from a 63 year old female consumer with a compromised immune system, fibromyalgia, asthma, allergies to codeine, vicodin, iron, keflex, pamelor, all anti-inflammatory medicines, all anti-depressant medicines, all anti-seizure medicines and levaquin and chilli pepper allergy who on 19-JAN-2007 was vaccinated with a 0.65 ml dose of ZOSTAVAX (Merck) (lot # 652966/0722P). Concomitant therapy included SYNTHROID, LIPITOR, Ateolol (manufacturer unknown) and omeprazole (MSD). "Two days later," on 21-JAN-2007 the patient developed swollen lymph nodes in her neck, knots "all up and down" her arm (also reported as 3 knots on her arm above the injection site), a large red rash on the injection arm, pain all over her body, a sore stiff neck, a burning sensation inside her nose, and her chest teele itchy in the respiratory area. The patient reported that she also experienced a cough that she developed 48-72 hours after vaccination. It was reported that the side effects have gotten increasingly worse. Unspecified medical attention was sought. At the time of the report the patient had not recovered. Follow-up information from the patient's primary physician stated that his office did not administer the vaccine and did not have any additional information. Additional information was received from the consumer who reported that the lot number previously provided was incorrect. The correct ZOSTAVAX (Merck) lot number is 654003/1405F. The consumer also reported that she has not had any improvement. The pain in her neck and shoulders was worse and it triggered and episode of fibromyalgia. Additional information has been requested.
Age: 63.0
Sex: F
Vaccine: VARZOS, VARZOS, VARZOS
Symptoms: Pain, Tenderness
Clinical narrative: Information has been received from a nurse practitioner concerning a 63 year old female who on 19-JAN-2007 was vaccinated with a dose of Zostavax (lot # 654603/1405F). There was no concomitant medication. On 21-JAN-2007 the patient developed arm soreness and cold like symptoms. Medical attention was sought. The patient was treated with lidocaine cream for her sore arm. There was no product quality complaint involved. No further information was available. Additional information has been requested. This is in follow-up to report(s) previously submitted on 3/14/2007: 6/22/2007. Information has been received from a 63 year old female consumer with a compromised immune system, fibromyalgia, asthma, allergies to codeine, vicodin, iron, keflex, pamelor, all anti-inflammatory medicines, all anti-depressant medicines, all anti-seizure medicines and levaquin and chilli pepper allergy who on 19-JAN-2007 was vaccinated with a 0.65 ml dose of ZOSTAVAX (Merck) (lot # 652966/0722P). Concomitant therapy included SYNTHROID, LIPITOR, Ateolol (manufacturer unknown) and omeprazole (MSD). "Two days later," on 21-JAN-2007 the patient developed swollen lymph nodes in her neck, knots "all up and down" her arm (also reported as 3 knots on her arm above the injection site), a large red rash on the injection arm, pain all over her body, a sore stiff neck, a burning sensation inside her nose, and her chest teele itchy in the respiratory area. The patient reported that she also experienced a cough that she developed 48-72 hours after vaccination. It was reported that the side effects have gotten increasingly worse. Unspecified medical attention was sought. At the time of the report the patient had not recovered. Follow-up information from the patient's primary physician stated that his office did not administer the vaccine and did not have any additional information. Additional information was received from the consumer who reported that the lot number previously provided was incorrect. The correct ZOSTAVAX (Merck) lot number is 654003/1405F. The consumer also reported that she has not had any improvement. The pain in her neck and shoulders was worse and it triggered and episode of fibromyalgia. Additional information has been requested.
Age: 63.0
Sex: F
Vaccine: VARZOS, VARZOS, VARZOS
Symptoms: Chest discomfort, Cough, Injection site erythema, Injection site nodule, Injection site rash
Clinical narrative: Information has been received from a nurse practitioner concerning a 63 year old female who on 19-JAN-2007 was vaccinated with a dose of Zostavax (lot # 654603/1405F). There was no concomitant medication. On 21-JAN-2007 the patient developed arm soreness and cold like symptoms. Medical attention was sought. The patient was treated with lidocaine cream for her sore arm. There was no product quality complaint involved. No further information was available. Additional information has been requested. This is in follow-up to report(s) previously submitted on 3/14/2007: 6/22/2007. Information has been received from a 63 year old female consumer with a compromised immune system, fibromyalgia, asthma, allergies to codeine, vicodin, iron, keflex, pamelor, all anti-inflammatory medicines, all anti-depressant medicines, all anti-seizure medicines and levaquin and chilli pepper allergy who on 19-JAN-2007 was vaccinated with a 0.65 ml dose of ZOSTAVAX (Merck) (lot # 652966/0722P). Concomitant therapy included SYNTHROID, LIPITOR, Ateolol (manufacturer unknown) and omeprazole (MSD). "Two days later," on 21-JAN-2007 the patient developed swollen lymph nodes in her neck, knots "all up and down" her arm (also reported as 3 knots on her arm above the injection site), a large red rash on the injection arm, pain all over her body, a sore stiff neck, a burning sensation inside her nose, and her chest teele itchy in the respiratory area. The patient reported that she also experienced a cough that she developed 48-72 hours after vaccination. It was reported that the side effects have gotten increasingly worse. Unspecified medical attention was sought. At the time of the report the patient had not recovered. Follow-up information from the patient's primary physician stated that his office did not administer the vaccine and did not have any additional information. Additional information was received from the consumer who reported that the lot number previously provided was incorrect. The correct ZOSTAVAX (Merck) lot number is 654003/1405F. The consumer also reported that she has not had any improvement. The pain in her neck and shoulders was worse and it triggered and episode of fibromyalgia. Additional information has been requested.
Age: 63.0
Sex: F
Vaccine: VARZOS, VARZOS, VARZOS
Symptoms: Lymphadenopathy, Musculoskeletal stiffness, Nasal discomfort, Pain, Pruritus
Clinical narrative: Information has been received from a nurse practitioner concerning a 63 year old female who on 19-JAN-2007 was vaccinated with a dose of Zostavax (lot # 654603/1405F). There was no concomitant medication. On 21-JAN-2007 the patient developed arm soreness and cold like symptoms. Medical attention was sought. The patient was treated with lidocaine cream for her sore arm. There was no product quality complaint involved. No further information was available. Additional information has been requested. This is in follow-up to report(s) previously submitted on 3/14/2007: 6/22/2007. Information has been received from a 63 year old female consumer with a compromised immune system, fibromyalgia, asthma, allergies to codeine, vicodin, iron, keflex, pamelor, all anti-inflammatory medicines, all anti-depressant medicines, all anti-seizure medicines and levaquin and chilli pepper allergy who on 19-JAN-2007 was vaccinated with a 0.65 ml dose of ZOSTAVAX (Merck) (lot # 652966/0722P). Concomitant therapy included SYNTHROID, LIPITOR, Ateolol (manufacturer unknown) and omeprazole (MSD). "Two days later," on 21-JAN-2007 the patient developed swollen lymph nodes in her neck, knots "all up and down" her arm (also reported as 3 knots on her arm above the injection site), a large red rash on the injection arm, pain all over her body, a sore stiff neck, a burning sensation inside her nose, and her chest teele itchy in the respiratory area. The patient reported that she also experienced a cough that she developed 48-72 hours after vaccination. It was reported that the side effects have gotten increasingly worse. Unspecified medical attention was sought. At the time of the report the patient had not recovered. Follow-up information from the patient's primary physician stated that his office did not administer the vaccine and did not have any additional information. Additional information was received from the consumer who reported that the lot number previously provided was incorrect. The correct ZOSTAVAX (Merck) lot number is 654003/1405F. The consumer also reported that she has not had any improvement. The pain in her neck and shoulders was worse and it triggered and episode of fibromyalgia. Additional information has been requested.
Age: 63.0
Sex: F
Vaccine: VARZOS, VARZOS, VARZOS
Symptoms: Respiratory disorder, Skin nodule
Clinical narrative: Information has been received from a nurse practitioner concerning a 63 year old female who on 19-JAN-2007 was vaccinated with a dose of Zostavax (lot # 654603/1405F). There was no concomitant medication. On 21-JAN-2007 the patient developed arm soreness and cold like symptoms. Medical attention was sought. The patient was treated with lidocaine cream for her sore arm. There was no product quality complaint involved. No further information was available. Additional information has been requested. This is in follow-up to report(s) previously submitted on 3/14/2007: 6/22/2007. Information has been received from a 63 year old female consumer with a compromised immune system, fibromyalgia, asthma, allergies to codeine, vicodin, iron, keflex, pamelor, all anti-inflammatory medicines, all anti-depressant medicines, all anti-seizure medicines and levaquin and chilli pepper allergy who on 19-JAN-2007 was vaccinated with a 0.65 ml dose of ZOSTAVAX (Merck) (lot # 652966/0722P). Concomitant therapy included SYNTHROID, LIPITOR, Ateolol (manufacturer unknown) and omeprazole (MSD). "Two days later," on 21-JAN-2007 the patient developed swollen lymph nodes in her neck, knots "all up and down" her arm (also reported as 3 knots on her arm above the injection site), a large red rash on the injection arm, pain all over her body, a sore stiff neck, a burning sensation inside her nose, and her chest teele itchy in the respiratory area. The patient reported that she also experienced a cough that she developed 48-72 hours after vaccination. It was reported that the side effects have gotten increasingly worse. Unspecified medical attention was sought. At the time of the report the patient had not recovered. Follow-up information from the patient's primary physician stated that his office did not administer the vaccine and did not have any additional information. Additional information was received from the consumer who reported that the lot number previously provided was incorrect. The correct ZOSTAVAX (Merck) lot number is 654003/1405F. The consumer also reported that she has not had any improvement. The pain in her neck and shoulders was worse and it triggered and episode of fibromyalgia. Additional information has been requested.
Age: 63.0
Sex: F
Vaccine: VARZOS, VARZOS, VARZOS
Symptoms: Burning sensation, Cough, Erythema, Fibromyalgia, Lymphadenopathy
Clinical narrative: Information has been received from a 63 year old female consumer with a compromised immune system, fibromyalgia, asthma, and allergies to codeine, vicodin, iron, all anti-inflammatory medicines, all anti-depressant medicines, all anti-seizure medicines and levaquin, who on 19-JAN-2007 was vaccinated with a 0.65 ml dose of Zostavax (lot # 652966/0722F). Concomitant therapy included SYNTHROID, LIPITOR, atenolol and omeprazole. "Two days later," on 21-JAN-2007 the patient developed swollen lymph nodes in her neck, knots "all up and down" her arm (also reported as 3 knots on her arm above the injection site), a large red rash on the injection arm, pain all over her body, a sore stiff neck, a burning sensation inside her nose, and her chest "feels itchy in the respiratory area." The patient reported that she also experienced a cough that she developed 48-72 hours after vaccination. It was reported that the side effects have gotten increasingly worse. Unspecified medical attention was sought. At the time of the report the patient had not recovered. Additional information has been requested.
Age: 63.0
Sex: F
Vaccine: VARZOS, VARZOS, VARZOS
Symptoms: Musculoskeletal stiffness, Nasopharyngitis, Neck pain, Pain, Pain in extremity
Clinical narrative: Information has been received from a 63 year old female consumer with a compromised immune system, fibromyalgia, asthma, and allergies to codeine, vicodin, iron, all anti-inflammatory medicines, all anti-depressant medicines, all anti-seizure medicines and levaquin, who on 19-JAN-2007 was vaccinated with a 0.65 ml dose of Zostavax (lot # 652966/0722F). Concomitant therapy included SYNTHROID, LIPITOR, atenolol and omeprazole. "Two days later," on 21-JAN-2007 the patient developed swollen lymph nodes in her neck, knots "all up and down" her arm (also reported as 3 knots on her arm above the injection site), a large red rash on the injection arm, pain all over her body, a sore stiff neck, a burning sensation inside her nose, and her chest "feels itchy in the respiratory area." The patient reported that she also experienced a cough that she developed 48-72 hours after vaccination. It was reported that the side effects have gotten increasingly worse. Unspecified medical attention was sought. At the time of the report the patient had not recovered. Additional information has been requested.
Age: 63.0
Sex: F
Vaccine: VARZOS, VARZOS, VARZOS
Symptoms: Pruritus, Rash
Clinical narrative: Information has been received from a 63 year old female consumer with a compromised immune system, fibromyalgia, asthma, and allergies to codeine, vicodin, iron, all anti-inflammatory medicines, all anti-depressant medicines, all anti-seizure medicines and levaquin, who on 19-JAN-2007 was vaccinated with a 0.65 ml dose of Zostavax (lot # 652966/0722F). Concomitant therapy included SYNTHROID, LIPITOR, atenolol and omeprazole. "Two days later," on 21-JAN-2007 the patient developed swollen lymph nodes in her neck, knots "all up and down" her arm (also reported as 3 knots on her arm above the injection site), a large red rash on the injection arm, pain all over her body, a sore stiff neck, a burning sensation inside her nose, and her chest "feels itchy in the respiratory area." The patient reported that she also experienced a cough that she developed 48-72 hours after vaccination. It was reported that the side effects have gotten increasingly worse. Unspecified medical attention was sought. At the time of the report the patient had not recovered. Additional information has been requested.
Age: 63.0
Sex: F
Vaccine: VARZOS, VARZOS, VARZOS
Symptoms: Burning sensation, Cough, Injection site mass, Lymphadenopathy, Musculoskeletal stiffness
Clinical narrative: Information has been received from a 63 year old female consumer with a compromised immune system, fibromyalgia, asthma, and allergies to codeine, vicodin, iron, all anti-inflammatory medicines, all anti-depressant medicines, all anti-seizure medicines and levaquin, who on 19-JAN-2007 was vaccinated with a 0.65 ml dose of Zostavax (lot # 652966/0722F). Concomitant therapy included SYNTHROID, LIPITOR, atenolol and omeprazole. "Two days later," on 21-JAN-2007 the patient developed swollen lymph nodes in her neck, knots "all up and down" her arm (also reported as 3 knots on her arm above the injection site), a large red rash on the injection arm, pain all over her body, a sore stiff neck, a burning sensation inside her nose, and her chest "feels itchy in the respiratory area." The patient reported that she also experienced a cough that she developed 48-72 hours after vaccination. It was reported that the side effects have gotten increasingly worse. Unspecified medical attention was sought. At the time of the report the patient had not recovered. Additional information has been requested.
Age: 63.0
Sex: F
Vaccine: VARZOS, VARZOS, VARZOS
Symptoms: Pain, Tenderness
Clinical narrative: Information has been received from a 63 year old female consumer with a compromised immune system, fibromyalgia, asthma, and allergies to codeine, vicodin, iron, all anti-inflammatory medicines, all anti-depressant medicines, all anti-seizure medicines and levaquin, who on 19-JAN-2007 was vaccinated with a 0.65 ml dose of Zostavax (lot # 652966/0722F). Concomitant therapy included SYNTHROID, LIPITOR, atenolol and omeprazole. "Two days later," on 21-JAN-2007 the patient developed swollen lymph nodes in her neck, knots "all up and down" her arm (also reported as 3 knots on her arm above the injection site), a large red rash on the injection arm, pain all over her body, a sore stiff neck, a burning sensation inside her nose, and her chest "feels itchy in the respiratory area." The patient reported that she also experienced a cough that she developed 48-72 hours after vaccination. It was reported that the side effects have gotten increasingly worse. Unspecified medical attention was sought. At the time of the report the patient had not recovered. Additional information has been requested.
Age: 63.0
Sex: F
Vaccine: VARZOS, VARZOS, VARZOS
Symptoms: Chest discomfort, Cough, Injection site erythema, Injection site nodule, Injection site rash
Clinical narrative: Information has been received from a 63 year old female consumer with a compromised immune system, fibromyalgia, asthma, and allergies to codeine, vicodin, iron, all anti-inflammatory medicines, all anti-depressant medicines, all anti-seizure medicines and levaquin, who on 19-JAN-2007 was vaccinated with a 0.65 ml dose of Zostavax (lot # 652966/0722F). Concomitant therapy included SYNTHROID, LIPITOR, atenolol and omeprazole. "Two days later," on 21-JAN-2007 the patient developed swollen lymph nodes in her neck, knots "all up and down" her arm (also reported as 3 knots on her arm above the injection site), a large red rash on the injection arm, pain all over her body, a sore stiff neck, a burning sensation inside her nose, and her chest "feels itchy in the respiratory area." The patient reported that she also experienced a cough that she developed 48-72 hours after vaccination. It was reported that the side effects have gotten increasingly worse. Unspecified medical attention was sought. At the time of the report the patient had not recovered. Additional information has been requested.
Age: 63.0
Sex: F
Vaccine: VARZOS, VARZOS, VARZOS
Symptoms: Lymphadenopathy, Musculoskeletal stiffness, Nasal discomfort, Pain, Pruritus
Clinical narrative: Information has been received from a 63 year old female consumer with a compromised immune system, fibromyalgia, asthma, and allergies to codeine, vicodin, iron, all anti-inflammatory medicines, all anti-depressant medicines, all anti-seizure medicines and levaquin, who on 19-JAN-2007 was vaccinated with a 0.65 ml dose of Zostavax (lot # 652966/0722F). Concomitant therapy included SYNTHROID, LIPITOR, atenolol and omeprazole. "Two days later," on 21-JAN-2007 the patient developed swollen lymph nodes in her neck, knots "all up and down" her arm (also reported as 3 knots on her arm above the injection site), a large red rash on the injection arm, pain all over her body, a sore stiff neck, a burning sensation inside her nose, and her chest "feels itchy in the respiratory area." The patient reported that she also experienced a cough that she developed 48-72 hours after vaccination. It was reported that the side effects have gotten increasingly worse. Unspecified medical attention was sought. At the time of the report the patient had not recovered. Additional information has been requested.
Age: 63.0
Sex: F
Vaccine: VARZOS, VARZOS, VARZOS
Symptoms: Respiratory disorder, Skin nodule
Clinical narrative: Information has been received from a 63 year old female consumer with a compromised immune system, fibromyalgia, asthma, and allergies to codeine, vicodin, iron, all anti-inflammatory medicines, all anti-depressant medicines, all anti-seizure medicines and levaquin, who on 19-JAN-2007 was vaccinated with a 0.65 ml dose of Zostavax (lot # 652966/0722F). Concomitant therapy included SYNTHROID, LIPITOR, atenolol and omeprazole. "Two days later," on 21-JAN-2007 the patient developed swollen lymph nodes in her neck, knots "all up and down" her arm (also reported as 3 knots on her arm above the injection site), a large red rash on the injection arm, pain all over her body, a sore stiff neck, a burning sensation inside her nose, and her chest "feels itchy in the respiratory area." The patient reported that she also experienced a cough that she developed 48-72 hours after vaccination. It was reported that the side effects have gotten increasingly worse. Unspecified medical attention was sought. At the time of the report the patient had not recovered. Additional information has been requested.
Age: 62.0
Sex: F
Vaccine: VARZOS
Symptoms: Induration, Injection site nodule, Injection site pain
Clinical narrative: Information has been received from a certified medical assistant concerning a 62 year old female employee who on 05 Feb 2007 was vaccinated IM with a dose of Zostavax. Subsequently she experienced a very painful, hard nodule at the injection site. Unspecified medical attention was sought. There was no product quality complaint involved. No further information was available. Additional information has been requested.
Age: 27.0
Sex: U
Vaccine: VARZOS
Symptoms: No adverse effect, Wrong drug administered
Clinical narrative: Information has been received from a registered nurse concerning a 27 year old patient who on 06 Feb 2007 was inadvertently vaccinated with a SC dose of Zostavax instead of a dose of Varivax. The event was a nursing error, not product confusion. No adverse experience was related to this event. A product quality complaint was not involved.   Additional information has been received from the registered nurse who reported that the event was not a product issue. The medical assistant who gave the vaccination did not validate what she was giving by checking with the physician. There was no adverse effect and the reported stated that "it was their own fault." The patient was told to stay away from pregnant women and people undergoing chemotherapy. Additional information has been requested.
Age: 49.0
Sex: F
Vaccine: VARZOS
Symptoms: Accidental exposure, Herpes zoster, Pain, Skin lesion
Clinical narrative: Information has been received from a physician concerning a female nurse, possibly in her late 40's, who on 03 Jan 2007 spilled Zostavax on her hand when she was drawing it up from the vial to administer to a patient. She developed pain ten days later on 13 Jan 2007 and lesions thirteen days later on 16 Jan 2007. Unspecified medical attention was sought. Subsequently the patient recovered. There was no product quality compliant involved. Additional information has been requested. 06/22/07 This is in follow-up to report(s) previously submitted on 3/14/2007. Information has been received from a physician concerning a 49 year old female with no medical history or allergies who on 09-JAN-2007 (previously reported as 03-JAN-2007) spilled ZOSTAVAX (Oka/Merck) (lot # 656412/1476F) on her hand when she was drawing it up from the vial to administer to a patient. She developed pain ten days later on 13-JAN-2007 and lesions thirteen days later on 16-JAN-2007. It was later reported that on 23-JAN-2007 at 7:00 am the patient was diagnosed with shingles. Unspecified medical attention was sought. Subsequently the patient recovered. There was no product quality complaint involved. Additional information is not expected.
Age: 70.0
Sex: F
Vaccine: VARZOS
Symptoms: Rash
Clinical narrative: Information has been received from a physician concerning a female patient in her 70's who on 23 Jan 2007 was vaccinated with a dose of Zostavax vaccine live. On 02 Feb 2007 the patient developed a rash on her face. Unspecified medical attention was sought. There was no product quality complaint involved. No other information was provided. No further information is available.
Age: 64.0
Sex: F
Vaccine: VARZOS
Symptoms: Feeling hot, Hypokinesia, Injection site erythema, Injection site induration, Injection site swelling
Clinical narrative: Information has been received from a medical assistant concerning a 65 year old female with a history of arthritis, vitamin B12 deficiency, hyperlipidaemia and hypothyroidism who on 06 Feb 2007 was vaccinated with a dose of Zostavax (lot #656412/1476F). There was no concomitant medication. Subsequently the patient's vaccination arm was hard, swollen and red. The patient also had pain in both hands. She could hardly move one wrist, was achy and felt feverish, but had no fever. Her non vaccination arm and shoulder were painful She was prescribed antihistamines. At the time of the report, the patient had not recovered. There was no product quality compliant involved. Additional information has been requested. This is in follow-up to report (s) previously submitted on 3/14/2007. The patient recovered after two days, on approximately 08-Feb-2007. No further information is expected.
Age: 64.0
Sex: F
Vaccine: VARZOS
Symptoms: Musculoskeletal pain, Pain, Pain in extremity
Clinical narrative: Information has been received from a medical assistant concerning a 65 year old female with a history of arthritis, vitamin B12 deficiency, hyperlipidaemia and hypothyroidism who on 06 Feb 2007 was vaccinated with a dose of Zostavax (lot #656412/1476F). There was no concomitant medication. Subsequently the patient's vaccination arm was hard, swollen and red. The patient also had pain in both hands. She could hardly move one wrist, was achy and felt feverish, but had no fever. Her non vaccination arm and shoulder were painful She was prescribed antihistamines. At the time of the report, the patient had not recovered. There was no product quality compliant involved. Additional information has been requested. This is in follow-up to report (s) previously submitted on 3/14/2007. The patient recovered after two days, on approximately 08-Feb-2007. No further information is expected.
Sex: F
Vaccine: VARZOS
Symptoms: Injection site bruising, Pain in extremity
Clinical narrative: Information has been received from a female pharmacist who on 16 Jan 2007 was vaccinated a dose with Zostavax.  On 17 Jan 2007 the patient experienced slight soreness in her upper arm and bruising around the injection site. She did not seek medical attention. Subsequently she recovered. There was no product quality complaint involved. No further information is available.
Age: 62.0
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster, Pain
Clinical narrative: Information has been received from a physician concerning a 62 year old male who on approximately 26-JAN-2007 was vaccinated with a dose of Varicella. Concomitant therapy included multivitamins (unspecified). Three days later, on approximately 29-JAN-2007, the patient returned to the physician's office with a "bad case of shingles." The physician gave the patient valacyclovir hydrochloride (VALTREX) and the patient is still in pain. At the time of the report, the patient had not recovered. A product quality complaint was not involved.
Sex: U
Vaccine: VARZOS
Symptoms: Arthralgia, Blister, Herpes zoster
Clinical narrative: Information has been received from a physician concerning a patient who "recently," in 2007, was vaccinated with a dose of Zostavax. On an unspecified date in 2007, the patient developed shingles. Unspecified medical attention was sought. a product quality complaint was not involved. Additional information was received from a nurse in the physician's office who reported that the patient's shingles did resolve. The patient's shingles were described as "kind of like sunburn" and the lesions were drying up. The patient was considered recovered. Follow up information received on 01-OCT-2007 from the consumer indicated that she wishes to be reimbursed for the cost of the vaccine as well as the cost of Valtrex and doctor visits. She noted that within 24 hours of receiving the vaccine, she developed a "sore" on her left arm. The next day she had "several sores" on her left arm. She developed 7 blisters on her left arm, and her skin was sensitive on her left arm and shoulder and the left side of her neck and face. She was experiencing "joint pain" on 10-FEB-2007. No further information is expected. Shingles was determined to be another important medical event by the physician.
Age: 72.0
Sex: F
Vaccine: PPV, VARZOS
Symptoms: Rash, Vomiting
Clinical narrative: Information has been received from a health professional concerning a 72 year old white female with no known drug allergies who on 29-JAN-2007 was vaccinated in the left deltoid with a first dose of Zostavax (lot # 656413/1477F). Concomitant vaccination the same day included a dose of Pneumovax. Other concomitant medication included CELEBREX, DIOVAN, EFFEXOR XR and alendronate sodium. No illness was noted at the time of vaccination. On 29-JAN-2007 the patient started vomiting and had a rash for two days. The vomiting lasted 24 ours. Medical attention was not sought. It was reported that the patient had no adverse events following prior vaccinations. Additional information has been requested.
Age: 71.0
Sex: F
Vaccine: VARZOS
Symptoms: Genital herpes, Headache
Clinical narrative: Information has been received from a health professional concerning a 71 year old female with a history of herpes simplex II, irritable bowel syndrome and gastroesophageal reflux disease who on 09-FEB-2007 was vaccinated SC in the left upper arm with a first dose of ZOSTAVAX(Merck) (lot # 656606/0033U. There was no illness at the time of vaccination. On 12-FEB-2007 the patient developed an outbreak of genital herpes. The patient self-treated with acyclovir starting 12-FEB-2007 and then contacted the office by phone on 13-FEB-2007. No laboratory tests were performed. At the time of the report, the patient had not recovered. There was no product quality complaint involved. Additional information has been requested.  Additional informatio indicated that on 12-FEB-2007 the patient developed a headache and herpez simplex II outbreak. The patient tool VALTREX and subsequentlt recovered.  No further information is expecetd.
Age: 53.0
Sex: M
Vaccine: VARZOS
Symptoms: Inappropriate schedule of drug administration, Paraesthesia
Clinical narrative: Information has been received from a physician concerning a 53 year old male who on 20-DEC-2006 was vaccinated SC with a dose of Zostavax> on 20-DEC-2006 the patient experienced a tingling sensation in the arm, down the arm and into the finger tips in the same arm the vaccine was given. On 13-FEB-2007 the patient was seen for an office visit and the tingling sensation has not gone away. There was no product quality complaint involved. Additional information has been requested.
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Blister, Erythema
Clinical narrative: Information has been received from a physician concerning a female patient between 65 to 70 years old, who in approximately January 2007, was vaccinated with a dose of Zostavax. Subsequently within two weeks of vaccination, the patient experienced red blisters throughout her body. Unspecified medical attention was sought. There was no product quality complaint involved. Additional information has been requested.
Age: 50.0
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster, Inappropriate schedule of drug administration, Oral mucosal blistering, Skin lesion
Clinical narrative: Information has been received from a 50 year old female nurse assistant with allergies to codeine and monosodium glutamate and a history of shingles who on 14-DEC-2006 was vaccinated SC with a dose of Zostavax. Concomitant therapy included vitamins (unspecified). Subsequently she developed "blisters" on the lateral part of her tongue. She also experienced a shingles lesion on her eyebrow. Unspecified medical attention was sought. She was being treated with VALTREX. At the time of the report, the patient had not recovered. There was no product quality complaint involved. No further information is expected.
Age: 62.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site reaction, Skin warm
Clinical narrative: Information has been received from a health professional concerning an approximately 62 year old female nurse who on 06-FEB-2007 was vaccinated with a dose of Zostavax. Subsequently she experienced an injection site reaction described as a 3" diameter raised red area at the injection site. Unspecified medical attention was sought. At the time of the report, the patient was recovering. There was no product quality complaint involved. Additional information has been requested. 06/22/07 This is in follow-up to report(s) previously submitted on 3/14/2007. Information has been received from a health professional concerning an approximately 62 year old female with no pre-existing medical history or allergies, who on 06-FEB-2007 in the AM was vaccinated subcutaneously into the left arm with a first dose of ZOSTAVAX (Oka/Merck) (Lot # 656608/0032U). There was no illness at the time of vaccination. Subsequently the patient developed an injection site reaction described as a 3" diameter raised red area at the injection site. When the patient woke up on 07 FEB 2007 the site had become erythematous, hot to touch, 6-7 cm in circumference. It remained erythematous for two to three weeks. It was pruritic during that time. Unspecified medical attention was sought. There was no product quality complaint involved. At the time of the report, the patient had recovered. There were no lab diagnostic studies performed. No further information is expected.
Age: 74.0
Sex: M
Vaccine: VARZOS
Symptoms: Body temperature, Erythema, Rash macular
Clinical narrative: Information has been received from a nurse practitioner concerning a 74 year old male with hypertension, hypercholesterolaemia, depression, and no allergies and a history of coronary artery bypass who on 14-FEB-2007 was vaccinated SC in the right arm with a 0.65 ml dose of Zostavax. Concomitant therapy included TOPROL XL TABLETS, LIPITOR, CELEXA, HYTRIN, and aspirin 81 mg. On 15-FEB-2007, within 24 hours of vaccination, the patient developed a rash. The patient presented to the doctor's office on 15-FEB-2007 with a red, macular rash on both ankles and some on the waist. The right ankle and descending to the lower extremities had eight small macular spots. The left ankle descending to the lower extremities had four macular spots, which were not itchy or tingling. The patient did not have a fever. No diagnostic laboratory tests were performed. A product quality complaint was not involved. Additional information has been requested.
Age: 38.0
Sex: F
Vaccine: VARZOS
Symptoms: Accidental exposure, Herpes zoster, Rash
Clinical narrative: Information has been received from a 38 year old female nurse who administered five vaccinations with a dose of Zostavax. During the time frame in which she administered the vaccines, she developed a shingles-like rash on the lower left-hand side of her back. Unspecified medical attention was sought and the rash subsequently resolved. A product quality complaint was not involved. Additional information has been requested.
Age: 82.0
Sex: M
Vaccine: VARZOS
Symptoms: Erythema, Pruritus, Rash, Swelling
Clinical narrative: Information has been received from a physician concerning an 82 year old male with an unspecified urological condition and dermatitis of the hands during winter seasons and a history of photosensitivity with Hytrin who on 15-DEC-2006 was vaccinated SC with a dose of Zostavax (lot # 652946/1012F). Concomitant therapy included simvastatin (manufacturer unknown), Uroxatral, Adodart. On approximately 13-FEB-2007, the patient developed a non-VZV rash. The patient initially experienced itching of his face which then developed into redness and swelling. The rash progressed to his lower jaw, arms, and abdomen. The patient was being treated with Zyrtec and the physician gave him a prescription for a Medrol Dosepak. The physician told the patient not to fill the prescription unless the rash worsened. No diagnostic laboratory tests were performed. At the time of the report, the patient had not recovered. The physician did not think that the rash was related to therapy with Zostavax. A product quality complaint was not involved. Additional information has been requested.
Sex: F
Vaccine: VARZOS
Symptoms: Accidental exposure, Erythema
Clinical narrative: Information has been received from a female registered nurse with a history of hives who on an unspecified date was vaccinating a patient SC with a dose Zostavax. While administering the vaccination, some of the vaccine got into a cut that was on her finger. As a result, her finger became "real red". The nurse recovered on an unspecified date. It was noted that the vaccinee was given the full dose with no issue. A product quality complaint was not involved. No further information is available.
Sex: U
Vaccine: VARZOS
Symptoms: Injection site reaction, Skin lesion
Clinical narrative: Information has been received from a physician concerning a patient who was vaccinated with a dose of Zostavax. Subsequently the patient experienced lesions at the injection site. Unspecified medical attention was sought. There was no product quality complaint involved. Additional information has been requested.
Sex: U
Vaccine: HPV4, VARZOS
Symptoms: Accidental exposure, Wrong drug administered
Clinical narrative: Information has been received from a health professional concerning a patient who was vaccinated with a dose of Zostavax that was reconstituted with Gardasil. No symptoms were noted. The office manager reported it was human error. The vaccine was administered by a medical assistant who was working in the office as a temp and was unfamiliar with the office and the vaccine. There was no product quality complaint involved. Additional information has been requested.
Age: 51.0
Sex: F
Vaccine: VARZOS
Symptoms: Blister, Herpes zoster, Secondary transmission
Clinical narrative: Information has been received from female physician who was "recently" exposed to a patient who was vaccinated with a dose a Zostavax and developed shingles on 25-JAN-2007. On 11-FEB-2007 the physician developed two vesicular shingles lesions at the C8 dermatone. She also had other exposures to patients with herpes zoster. On 12-FEB-2007 she began therapy with valcyclovir. The physician has a history of chickenpox as child. Additional information has been requested. This is in follow-up to report (s). Additional information indicated that physician developed herpes zoster 22 dyas after VZV exposure during patient care, which lasted for less than 1 hour. On 11-Feb-2007 the physician developed herpes zoster on the right C-8 dermatone. Her maximum teperature was 98.6 F and other systemic symptoms included myalgia. The physician has a history of chickenpox as child at age 10. the physician was enrolled in Varicella zoster. Indentification Program to identify if VZV is prevent and if it is present to identify if it is associated with the wild (WT) VZV strain or with the Merck vaccine VZV strain. Specimens were obtained on 13-Feb-2007 from vaccines on th right arm C-B dermatome. Both specimens were negative, no VZV was identified. Subsquently the physician recovered completely from her experiences and was doing fine. No further information is expected.
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Blister, Rash, Rash pruritic
Clinical narrative: Information has been received from a registered nurse concerning a female patient over the age of 65 who on approximately 05-FEB-2007 was vaccinated SC with a dose of Zostavax. Five days after vaccination, on approximately 10-FEB-2007, the patient developed a rash on her chest described as itchy blisters. The rash covered her chest above her breast-line and spread from the right side to the left side of her body. Unspecified medical attention was sought. The nurse gave the patient hydrocortisone cream for the rash. A product quality complaint was not involved. Additional information has been requested.
Age: 87.0
Sex: F
Vaccine: VARZOS
Symptoms: Skin lesion, Varicella
Clinical narrative: Information has been received from a physician concerning an 87 year old female who on an unspecified date was vaccinated SC with a dose of Zostavax. Subsequently, three weeks after vaccination the patient developed "something like chickenpox." Unspecified medical attention was sought. It was not reported how many lesions the patient developed. The physician was unsure if it could be related to Zostavax. There was no product quality complaint involved. No further was provided. Additional information has been requested.
Age: 80.0
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a physician concerning an 80-year-old female who on 21-DEC-2006 was vaccinated with a dose of Zostavax. In early February 2007, the patient developed shingles in the chest region. It was noted that the shingles were in a staggered pattern. The patient has seen a dermatologist and has been prescribed Famvir for treatment. At the time of the report, the patient was recovering. A product quality complaint was not involved. Additional information has been requested.
Age: 78.0
Sex: F
Vaccine: VARZOS
Symptoms: Condition aggravated, Herpes zoster, Pain
Clinical narrative: This is follow-up to report(s) previously submitted on 3/14/2007. Information has been received from a pharmacist concerning a 78 year old female with coronary artery disease, hyperlipidaemia, diabetes, and chronic urinary tract infections and a history of shingles who on 14-FEB-2007 at 13:20 PM was vaccinated IM in the left deltoid with a first dose of ZOSTAVAX (Merck). Concomitant therapy included flaxseed, glucosamine, omega-3 marine triglycerides, grape seeds, metformin, glyburide, LIPITOR, digoxin, DIOVAN, aspirin and MACRODANTIN. There was no illness at the time of vaccination. On 19-FEB-2007 or 20-FEB-2007 the patient developed pain along her trunk. There was no rash or lesion noted. There was no pain, rash or lesion at the injection site. Unspecified medical attention was sought. There was no product quality complaint involved. Additional information has been requested. Additional information has been received from a nurse practitioner who noted that the patient reported having developed shingles pain on the right side of her body the day following administration, 15-FEB-2007. She was given VICODIN for pain and had no relief. She took a homeopathic medication for shingles which relieved all pain in 10 days. The patient was considered recovered. The patient had no adverse events following prior vaccination. No further information is expected.
Age: 83.0
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a pharmacist concerning an 83 year old male who on 15-FEB-2007 was vaccinated SC with the "usual dose" of Zostavax. Subsequently "may have possibly broke out in shingles". As of 20-FEB-2007, the patient was in the process of seeing the physician in order to confirm a diagnosis of shingles. There was no product quality complaint involved. Additional information has been requested.
Age: 18.0
Sex: F
Vaccine: VARZOS
Symptoms: Inappropriate schedule of drug administration, Medication error, Wrong drug administered
Clinical narrative: Information has been received from a physician concerning an 18 year old female who on 16-FEB-2007 was vaccinated with a dose of Zostavax instead of Varivax. The physician was unable to determine if there was product confusion. The patient was asymptomatic. Unspecified medical attention was sought. There was no product quality complaint involved. Additional information has been requested.
Age: 66.0
Sex: F
Vaccine: FLUX, VARZOS
Symptoms: Body temperature increased, Erythema, Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Information has been received from a health professional concerning a 66 year old female physician with no allergies or medical history on 10-NOV-2006 was vaccinated IM in the left deltoid with an 0.65 ml dose of Zostavax (lot # 652936/0981F). Concomitant therapy included ULTRAM. Twenty-four hours later, on 11-NOV-2006, the patient developed a fever of 101 degrees. Her left arm and deltoid injection site injection site became red, swollen, and hot to the touch. Unspecified medical attention was sought. No diagnostic laboratory tests were performed. The patient recovered on 12-NOV-2006. A product quality complaint was not involved. Additional information has been requested. This is in follow-up to report(s) previously submitted on 3/14/2007. Initial information has been received from a medical assistant concerning a 66 year old female physician with no allergies or medical history who on 10-NOV-2006 was vaccinated SC (previously reported as IM) in the right (previously reported as left) deltoid with an 0.65 ml dose of ZOSTAVAX (lot # 652936/0981F). Additional information received from the physician indicated that the reaction was a reaction to the influenza virus vaccine (unspecified) (manufacturer unknown) (lot # 71829) and not ZOSTAVAX (Merck) (lot # 652936/0981F). No further information was reported. Additional information is not expected.